Developer docs
API playgroundTry for free, no card

Search company profiles

Metabolon

Full company profile

uuid00009kq

Namestring
Metabolon
Legal namestring
Metabolon, Inc.
Websiteurl
metabolon.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Metabolon, Inc. is a privately held metabolomics solutions company founded in 2000 and headquartered in Morrisville, North Carolina. The company provides untargeted and targeted metabolomics profiling services, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical companies, academic research institutions, contract research organizations, government agencies, and food and environmental researchers. Its core technology combines ultra-high-performance liquid chromatography with tandem accurate mass spectrometry (UHPLC/MS/MS) with the metabolomics industry's largest Level 1 annotated proprietary biochemical reference library, currently covering 5,400+ metabolites across 70+ biochemical pathways in a single biological sample. The company has analyzed more than 2 million samples, completed over 15,000 projects, and is cited in more than 4,000 peer-reviewed publications.

Metabolon's commercial architecture is platform-plus-services. Revenue is generated primarily through quote-based metabolomics testing services performed in ISO 9001:2015, CLIA-certified, and CAP-accredited labs, with a 45+ PhD scientific staff providing expert interpretation. In May 2026, the company expanded into a product-based model with the launch of the Metabolon Verus™ Metabolomics Profiling Kit, enabling laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house. Distribution is conducted through direct enterprise field sales, supported by content-driven marketing (scientific publications, webinars, conferences), with named customers including Merck, Johnson & Johnson, Kite (Gilead), Mayo Clinic, Cleveland Clinic, Johns Hopkins, the National Cancer Institute, the U.S. VA's Million Veteran Program, Genomics England, the Michael J. Fox Foundation, and the China Kadoorie Biobank.

The business has scaled through a combination of equity and debt financing, including a $25 million equity round in January 2023, a $60 million credit facility from Trinity Capital in May 2024, and additional rounds in 2025. The company employs 251–500 staff and has signaled continued expansion through large cohort partnerships, geographic expansion into Europe and Asia, and the addition of a CFO with M&A experience in early 2026.

Short descriptiontext

Metabolon provides untargeted and targeted metabolomics profiling, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical, academic, government, and foundation researchers, backed by the industry's largest Level 1 annotated metabolite reference library of 5,400+ metabolites across 70+ pathways.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMorrisville, United States
HQ citystring
Morrisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
metabolomics services, biomarker discovery, untargeted metabolomics, lipidomics panels, multiomics research
Industry3 codes
PRIMARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAALAN
Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Metabolomics Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Metabolomics Testing Services
TypeProfessional Services
Description

Metabolon provides laboratory testing services for metabolomics analysis. Services range from untargeted discovery metabolomics to targeted quantitative panels. Services are conducted in ISO 9001:2015 and CLIA-certified labs. Pricing is quote-based, indicating a project-based service model with customized engagement based on study requirements.

metabolon.com
2Metabolon Verus™ Kit Sales
TypeOne Time License
Description

Sale of the Metabolon Verus™ Metabolomics Profiling Kit, which extends centralized metabolomics capabilities directly to laboratories worldwide. This represents a product-based revenue stream that complements the service model by enabling labs to run standardized metabolomics workflows in their own environments.

prnewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing for metabolomics services
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing is quote-based and customized per project. Customers can request a quote, submit a study, or demo the data platform. No standard pricing tiers are publicly listed.

metabolon.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Metabolon Verus™
Description

The Metabolon Verus™ Metabolomics Profiling Kit is the company's first kit designed to extend cutting-edge centralized metabolomics capabilities directly to laboratories worldwide. It provides a standardized workflow for generating reproducible metabolomics data with integrated bioinformatics tools.

prnewswire.com
Core offering1 text field

Metabolon provides metabolomics laboratory testing and analysis services through its ISO 9001:2015 and CLIA-certified labs, anchored by the Global Discovery Panel untargeted service covering 70+ biochemical pathways and 5,400+ metabolites, complemented by targeted quantitative panels, microbiome and metagenomics services, biopharma research support, and an Integrated Bioinformatics Platform. The company also sells the Metabolon Verus™ Metabolomics Profiling Kit so laboratories with LC-MS capability can run standardized metabolomics workflows in-house.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 2,000,000+ samples analyzed in Metabolon's state-of-the-art research facility
+1 more record
Product overview1 text field

Metabolon is a metabolomics solutions company offering a platform-plus-services architecture. The core offerings include the Global Discovery Panel (untargeted metabolomics service covering 70+ biochemical pathways and 5,400+ metabolites), targeted metabolomics panels (including Amino Acids, Bile Acids, Free Fatty Acids, Short Chain Fatty Acids, Complex Lipids, and Sphingolipids panels), and the newly launched Metabolon Verus™ Metabolomics Profiling Kit (a standardized kit for labs to perform metabolomics in-house). The company's Integrated Bioinformatics Platform provides data analysis, visualization, biomarker discovery tools, multiomics integration, and microbiome analysis capabilities. Services are conducted in ISO 9001:2015 and CLIA-certified labs, with over 25 years of experience and more than 4,000 publications citing Metabolon data.

Product and service7 records
1Global Discovery Panel
CategoryUntargeted Metabolomics Service
Description

Untargeted metabolomics service providing broad coverage of metabolites across 70+ biochemical pathways with the highest confidence identification, designed for biopharma, academic, and government researchers pursuing biomarker discovery and mechanistic insights.

2Microbiome Panel
CategoryUntargeted Metabolomics Service
Description

Curated untargeted metabolomics panel screening 800+ small molecules relevant to microbiome research, supporting studies that integrate microbial community data with functional metabolic impacts.

3Targeted Metabolomics
CategoryTargeted Metabolomics Service
Description

Targeted metabolomics service providing absolute quantification of 1,000+ metabolites and lipids, including specialized panels for amino acids, bile acids, free fatty acids, short chain fatty acids, complex lipids, and sphingolipids, for biopharma and academic researchers.

4Metabolon Verus™ Metabolomics Profiling Kit
CategoryMetabolomics Kit Product
Description

Physical metabolomics profiling kit that enables laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house, including sample preparation, quality control, automated annotation, and integrated bioinformatics interpretation.

5Microbiome Research Solution
CategoryMicrobiome Solutions
Description

Integrated microbiome offering combining a curated metabolomics panel (800+ small molecules), six metagenomics sequencing options, and 12 bioinformatics tools for integrated analysis of microbial community information with functional metabolic impacts.

6Metagenomic Sequencing
CategorySequencing Service
Description

Metagenomics sequencing service offering six sequencing options to support microbiome and multiomics research, enabling analysis of microbial communities alongside metabolomics data.

7Biopharma Services
CategoryBiopharma Research Service
Description

End-to-end metabolomics services for biopharmaceutical customers covering target identification, biomarker discovery, growth media analysis, and pharmacokinetics to support drug discovery and development programs.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Genomics England
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-24
Description

Metabolon delivered a large-scale metabolomics dataset to Genomics England's 100,000 Genomes Project covering more than 7,500 participants. This marks the first time metabolomics data of this scale has been generated and delivered for integration with a major national genomic initiative. The dataset will advance rare disease research and be available to approved researchers through Genomics England's Trusted Research Environment.

en.prnasia.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Metabolon partnered with the Michael J. Fox Foundation to discover biomarkers and biological pathways related to Parkinson's disease. This collaboration supports the foundation's mission to find a cure for Parkinson's disease through research using Metabolon's metabolomics platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-17
Description

Metabolon's global metabolomics platform was used by Kite researchers to conduct the largest metabolomic analysis to date in CAR T-cell therapy. The study analyzed over 3,800 longitudinal serum, plasma, and cerebrospinal fluid samples across six clinical studies, identifying metabolic signatures that associate with severe neurological events.

4Million Veteran Program (U.S. Department of Veterans Affairs)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

Metabolon supported the Million Veteran Program's 62,000-sample dataset, providing biomarker analysis as part of a large multiomics research effort. This initiative explores health factors affecting veterans, offering insights applicable to broader public health and medical research.

newswire.ca
5China Kadoorie Biobank (CKB)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-09
Description

Metabolon partnered with the China Kadoorie Biobank to profile plasma metabolomics biomarkers using its Global Discovery Panel. The study initially covers 4,000 samples linked to other multiomics data and examines how lifestyle, environmental, genetic, and socioeconomic factors influence common diseases in underrepresented populations.

prnewswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Japanese metabolomics services company offering CE-MS and LC-MS based untargeted metabolomics profiling. Closely comparable business model and customer base to Metabolon, though smaller scale and Asia-Pacific anchored.

TypeDirect peer
Description

Austria-based metabolomics company offering both targeted metabolomics services and standardized kits/panels (e.g., MxP® Quant 500). Direct competitor in both service and kit-based metabolomics, particularly in European biopharma.

3Chenomx
TypeDirect peer
Description

Canadian metabolomics company offering NMR-based profiling services and proprietary software for metabolite identification. Comparable in offering metabolomics analysis with proprietary reference libraries, though uses NMR rather than LC-MS/MS.

TypeBroad incumbent
Description

Major mass spectrometry and NMR instrument vendor whose platforms underpin much of the metabolomics market. Relevant because Bruker also offers metabolomics software and increasingly service-style offerings, competing with Metabolon's workflows at the infrastructure layer.

TypeBroad incumbent
Description

Leading LC-MS instrument manufacturer whose ACQUITY UPLC and Xevo MS systems are widely used for metabolomics. Competes indirectly as instrument vendors increasingly bundle bioinformatics and standardized workflows that challenge centralized services.

TypeBroad incumbent
Description

Dominant life sciences instrumentation and services conglomerate offering mass spectrometers, software, and contract lab services through PPD. Competes across the full stack Metabolon touches, with substantially greater scale and breadth.

TypeBroad incumbent
Description

Global contract laboratory services provider with extensive clinical, pharma, and metabolomics-adjacent testing capabilities. Provides large-scale lab services infrastructure that competes for outsourced research testing budgets.

TypeEmerging player
Description

Proteomics biomarker discovery platform with PEA technology serving biopharma and academic researchers. Comparable in being a specialty omics platform vendor pursuing multiomics integration, though focused on proteomics rather than metabolomics.

TypeOthers
Description

Life sciences tools provider offering mass cytometry and multiomics instrumentation. Adjacent in serving the multiomics research market with enabling instrumentation, though not directly competing in metabolomics services.

TypeDirect peer
Description

German metabolomics services company (now part of Metabolon following 2017 acquisition, though operating semi-independently). Direct comparable in targeted and untargeted metabolomics services for pharma and academic research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds17 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Metabolon

Metabolomics Servicesmetabolon.com

Metabolon provides untargeted and targeted metabolomics profiling, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical, academic, government, and foundation researchers, backed by the industry's largest Level 1 annotated metabolite reference library of 5,400+ metabolites across 70+ pathways.

What Metabolon does

Metabolon, Inc. is a privately held metabolomics solutions company founded in 2000 and headquartered in Morrisville, North Carolina. The company provides untargeted and targeted metabolomics profiling services, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical companies, academic research institutions, contract research organizations, government agencies, and food and environmental researchers. Its core technology combines ultra-high-performance liquid chromatography with tandem accurate mass spectrometry (UHPLC/MS/MS) with the metabolomics industry's largest Level 1 annotated proprietary biochemical reference library, currently covering 5,400+ metabolites across 70+ biochemical pathways in a single biological sample. The company has analyzed more than 2 million samples, completed over 15,000 projects, and is cited in more than 4,000 peer-reviewed publications.

Metabolon's commercial architecture is platform-plus-services. Revenue is generated primarily through quote-based metabolomics testing services performed in ISO 9001:2015, CLIA-certified, and CAP-accredited labs, with a 45+ PhD scientific staff providing expert interpretation. In May 2026, the company expanded into a product-based model with the launch of the Metabolon Verus™ Metabolomics Profiling Kit, enabling laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house. Distribution is conducted through direct enterprise field sales, supported by content-driven marketing (scientific publications, webinars, conferences), with named customers including Merck, Johnson & Johnson, Kite (Gilead), Mayo Clinic, Cleveland Clinic, Johns Hopkins, the National Cancer Institute, the U.S. VA's Million Veteran Program, Genomics England, the Michael J. Fox Foundation, and the China Kadoorie Biobank.

The business has scaled through a combination of equity and debt financing, including a $25 million equity round in January 2023, a $60 million credit facility from Trinity Capital in May 2024, and additional rounds in 2025. The company employs 251–500 staff and has signaled continued expansion through large cohort partnerships, geographic expansion into Europe and Asia, and the addition of a CFO with M&A experience in early 2026.

Metabolon firmographics

Firmographics
Name
Metabolon
Legal name
Metabolon, Inc.
Website
https://metabolon.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
Metabolon provides untargeted and targeted metabolomics profiling, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical, academic, government, and foundation researchers, backed by the industry's largest Level 1 annotated metabolite reference library of 5,400+ metabolites across 70+ pathways.
Ownership category
akta.pro rank

Metabolon industry classification

Industry
Product category
Metabolomics Services
NAICS
Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAAALAN
Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays

Keywords

  • Metabolomics services
  • Biomarker discovery
  • Untargeted metabolomics
  • Lipidomics panels
  • Multiomics research

Where Metabolon is headquartered

Location

Headquarters

HQ city
Morrisville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Metabolon business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Metabolomics Testing Services: Metabolon provides laboratory testing services for metabolomics analysis. Services range from untargeted discovery metabolomics to targeted quantitative panels. Services are conducted in ISO 9001:2015 and CLIA-certified labs. Pricing is quote-based, indicating a project-based service model with customized engagement based on study requirements.
  2. Metabolon Verus™ Kit Sales: Sale of the Metabolon Verus™ Metabolomics Profiling Kit, which extends centralized metabolomics capabilities directly to laboratories worldwide. This represents a product-based revenue stream that complements the service model by enabling labs to run standardized metabolomics workflows in their own environments.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCustom project-based pricing for metabolomics services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Metabolon product offering

Product offering

Core offering

Metabolon provides metabolomics laboratory testing and analysis services through its ISO 9001:2015 and CLIA-certified labs, anchored by the Global Discovery Panel untargeted service covering 70+ biochemical pathways and 5,400+ metabolites, complemented by targeted quantitative panels, microbiome and metagenomics services, biopharma research support, and an Integrated Bioinformatics Platform. The company also sells the Metabolon Verus™ Metabolomics Profiling Kit so laboratories with LC-MS capability can run standardized metabolomics workflows in-house.

Product overview

Metabolon is a metabolomics solutions company offering a platform-plus-services architecture. The core offerings include the Global Discovery Panel (untargeted metabolomics service covering 70+ biochemical pathways and 5,400+ metabolites), targeted metabolomics panels (including Amino Acids, Bile Acids, Free Fatty Acids, Short Chain Fatty Acids, Complex Lipids, and Sphingolipids panels), and the newly launched Metabolon Verus™ Metabolomics Profiling Kit (a standardized kit for labs to perform metabolomics in-house). The company's Integrated Bioinformatics Platform provides data analysis, visualization, biomarker discovery tools, multiomics integration, and microbiome analysis capabilities. Services are conducted in ISO 9001:2015 and CLIA-certified labs, with over 25 years of experience and more than 4,000 publications citing Metabolon data.

Differentiator

Problem solved

Functional benefit

Brands

  • Metabolon Verus™: The Metabolon Verus™ Metabolomics Profiling Kit is the company's first kit designed to extend cutting-edge centralized metabolomics capabilities directly to laboratories worldwide. It provides a standardized workflow for generating reproducible metabolomics data with integrated bioinformatics tools.

Products and services

  • Global Discovery Panel Untargeted metabolomics service providing broad coverage of metabolites across 70+ biochemical pathways with the highest confidence identification, designed for biopharma, academic, and government researchers pursuing biomarker discovery and mechanistic insights.
  • Microbiome Panel Curated untargeted metabolomics panel screening 800+ small molecules relevant to microbiome research, supporting studies that integrate microbial community data with functional metabolic impacts.
  • Targeted Metabolomics Targeted metabolomics service providing absolute quantification of 1,000+ metabolites and lipids, including specialized panels for amino acids, bile acids, free fatty acids, short chain fatty acids, complex lipids, and sphingolipids, for biopharma and academic researchers.
  • Metabolon Verus™ Metabolomics Profiling Kit Physical metabolomics profiling kit that enables laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house, including sample preparation, quality control, automated annotation, and integrated bioinformatics interpretation.
  • Microbiome Research Solution Integrated microbiome offering combining a curated metabolomics panel (800+ small molecules), six metagenomics sequencing options, and 12 bioinformatics tools for integrated analysis of microbial community information with functional metabolic impacts.
  • Metagenomic Sequencing Metagenomics sequencing service offering six sequencing options to support microbiome and multiomics research, enabling analysis of microbial communities alongside metabolomics data.
  • Biopharma Services End-to-end metabolomics services for biopharmaceutical customers covering target identification, biomarker discovery, growth media analysis, and pharmacokinetics to support drug discovery and development programs.

Quantifiable outcome

  • 2,000,000+ samples analyzed in Metabolon's state-of-the-art research facility
  • +1 more outcomes

Companies that use Metabolon

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles3 records

Metabolon technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Metabolon partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Genomics EnglandcoreStrategic or Co-development Partner · 24 June 2026Metabolon delivered a large-scale metabolomics dataset to Genomics England's 100,000 Genomes Project covering more than 7,500 participants. This marks the first time metabolomics data of this scale has been generated and delivered for integration with a major national genomic initiative. The dataset will advance rare disease research and be available to approved researchers through Genomics England's Trusted Research Environment.
  • Michael J. Fox Foundation for Parkinson's ResearchcoreStrategic or Co-development Partner · 17 March 2026Metabolon partnered with the Michael J. Fox Foundation to discover biomarkers and biological pathways related to Parkinson's disease. This collaboration supports the foundation's mission to find a cure for Parkinson's disease through research using Metabolon's metabolomics platform.
  • Kite (Gilead company)coreStrategic or Co-development Partner · 17 February 2026Metabolon's global metabolomics platform was used by Kite researchers to conduct the largest metabolomic analysis to date in CAR T-cell therapy. The study analyzed over 3,800 longitudinal serum, plasma, and cerebrospinal fluid samples across six clinical studies, identifying metabolic signatures that associate with severe neurological events.
  • Million Veteran Program (U.S. Department of Veterans Affairs)coreStrategic or Co-development Partner · 4 November 2025Metabolon supported the Million Veteran Program's 62,000-sample dataset, providing biomarker analysis as part of a large multiomics research effort. This initiative explores health factors affecting veterans, offering insights applicable to broader public health and medical research.
  • China Kadoorie Biobank (CKB)coreStrategic or Co-development Partner · 9 September 2025Metabolon partnered with the China Kadoorie Biobank to profile plasma metabolomics biomarkers using its Global Discovery Panel. The study initially covers 4,000 samples linked to other multiomics data and examines how lifestyle, environmental, genetic, and socioeconomic factors influence common diseases in underrepresented populations.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Metabolon competitors and assessment

Company assessment

Direct peers

  • Human Metabolome Technologies (HMT): Japanese metabolomics services company offering CE-MS and LC-MS based untargeted metabolomics profiling. Closely comparable business model and customer base to Metabolon, though smaller scale and Asia-Pacific anchored.
  • Biocrates Life Sciences: Austria-based metabolomics company offering both targeted metabolomics services and standardized kits/panels (e.g., MxP® Quant 500). Direct competitor in both service and kit-based metabolomics, particularly in European biopharma.
  • Chenomx: Canadian metabolomics company offering NMR-based profiling services and proprietary software for metabolite identification. Comparable in offering metabolomics analysis with proprietary reference libraries, though uses NMR rather than LC-MS/MS.
  • Metabolomic Discoveries: German metabolomics services company (now part of Metabolon following 2017 acquisition, though operating semi-independently). Direct comparable in targeted and untargeted metabolomics services for pharma and academic research.

Broad incumbents

  • Bruker Corporation: Major mass spectrometry and NMR instrument vendor whose platforms underpin much of the metabolomics market. Relevant because Bruker also offers metabolomics software and increasingly service-style offerings, competing with Metabolon's workflows at the infrastructure layer.
  • Waters Corporation: Leading LC-MS instrument manufacturer whose ACQUITY UPLC and Xevo MS systems are widely used for metabolomics. Competes indirectly as instrument vendors increasingly bundle bioinformatics and standardized workflows that challenge centralized services.
  • Thermo Fisher Scientific: Dominant life sciences instrumentation and services conglomerate offering mass spectrometers, software, and contract lab services through PPD. Competes across the full stack Metabolon touches, with substantially greater scale and breadth.
  • Eurofins Scientific: Global contract laboratory services provider with extensive clinical, pharma, and metabolomics-adjacent testing capabilities. Provides large-scale lab services infrastructure that competes for outsourced research testing budgets.

Emerging players

  • Olink Holding: Proteomics biomarker discovery platform with PEA technology serving biopharma and academic researchers. Comparable in being a specialty omics platform vendor pursuing multiomics integration, though focused on proteomics rather than metabolomics.

Others

  • Standard BioTools (formerly Fluidigm): Life sciences tools provider offering mass cytometry and multiomics instrumentation. Adjacent in serving the multiomics research market with enabling instrumentation, though not directly competing in metabolomics services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Metabolon social profiles

Digital presence

Metabolon compliance and trust

Trust signal

Compliance2 records

Metabolon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Metabolon leadership team

Management profile

Number of profiles

Profiles4 records

Metabolon funding detail

Funding detail

Funding overview

Funding rounds17 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Metabolon M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metabolon

What does Metabolon do?

Metabolon provides metabolomics laboratory testing and analysis services through its ISO 9001:2015 and CLIA-certified labs, anchored by the Global Discovery Panel untargeted service covering 70+ biochemical pathways and 5,400+ metabolites, complemented by targeted quantitative panels, microbiome and metagenomics services, biopharma research support, and an Integrated Bioinformatics Platform. The company also sells the Metabolon Verus™ Metabolomics Profiling Kit so laboratories with LC-MS capability can run standardized metabolomics workflows in-house.

Is Metabolon a public or private company?

Metabolon is a private company. It is classified as venture growth investor backed and is currently operating.

When was Metabolon founded?

Metabolon was founded in 2000. It employs 101 to 250 people.

Where is Metabolon based?

Metabolon is headquartered in Morrisville, United States, in the North America region.

How does Metabolon make money?

Two revenue lines are on record. Metabolomics Testing Services are the primary driver. The others are metabolon Verus™ Kit Sales.

Who are Metabolon's main competitors?

Direct peers on record are Human Metabolome Technologies (HMT), Biocrates Life Sciences, Chenomx and Metabolomic Discoveries. Broad incumbents are Bruker Corporation, Waters Corporation, Thermo Fisher Scientific and Eurofins Scientific. Olink Holding is listed as an emerging player. Standard BioTools (formerly Fluidigm) is listed as an others.

Does Metabolon have an API?

No public API is recorded for Metabolon.

What industry is Metabolon in?

Metabolon's product category is Metabolomics Services. Its primary akta.pro industry code is HLAGANAG, Metabolomics & Lipidomics Services, with a secondary code of HLAGAFAC, DMPK / ADME & Bioanalysis. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireMetabolon Verus™ Metabolomics Profiling Kit Now Available to OrderMetabolon announced its Verus metabolomics profiling kit is now available to order, moving from early access to full commercial availability. A ring trial across eight labs detected an average of 735 metabolites per plasma sample with 89% overlap and a median correlation of 0.91 to a truth dataset. The kit is available in North America now, with international availability in early 2027.The Manila TimesMetabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics ResearchMetabolon, Inc. launched the Peak Science Grant Program, a quarterly initiative providing researchers with fully funded metabolomics studies and access to its analytical platform at no cost. The program selects one winning project per quarter, offering up to 100 sample analyses, bioinformatics tools, and scientific guidance to advance life sciences research.PR Newswire APACMetabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics ResearchMetabolon, Inc. announced the launch of its Peak Science Grant Program, a competitive quarterly initiative offering researchers no-cost access to its metabolomics platform, bioinformatics tools, scientific expertise, and analysis of up to 100 samples per winning project. The program is open to researchers in academia and industry across disease biology, translational research, nutrition, and related life science disciplines, with submissions evaluated on scientific impact, feasibility, and innovation. Applications for the current quarter close September 30, 2026, and finalists receive a 10% credit toward future Metabolon projects.PR NewswireMetabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics ResearchMetabolon launched the Peak Science Grant Program, a quarterly grant offering no-cost access to its metabolomics platform and services. Each quarter, three finalists are selected and one winning project receives a fully funded study, with applications due September 30 and December 31, 2026.Labroots Trending Science NewsIntroducing Metabolon Verus™: Bringing Untargeted Metabolomics Into Your LabMetabolon is launching Metabolon Verus, an untargeted metabolomics kit, via a webinar on July 28, 2026. The kit aims to bring Metabolon's workflow and data quality into laboratories, supporting scalable sample preparation and downstream biological insights across academic, clinical, and biopharma settings.citybizMetabolon Expands Microbiome Panel to Advance Functional Multiomics ResearchMetabolon expanded its Microbiome Panel to cover over 800 microbial metabolites, including short-chain fatty acids, bile acids, and diet-related compounds. The update adds 70+ biochemical pathways and absolute quantitation of short-chain fatty acids, supporting multiomic studies. The company has supported over 15,000 research projects and 4,000 publications.NewswireMetabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome ResearchMetabolon expanded its Microbiome Panel to screen over 800 microbiome-associated metabolites, including expanded coverage of food and nutrition-related metabolites. The panel targets researchers and biopharma teams, supporting biomarker identification and multiomic analyses. It is part of Metabolon's broader Microbiome Research Solution combining metabolomics, metagenomics, and bioinformatics.PR Newswire APACMetabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease ResearchMetabolon announced the successful completion and delivery of comprehensive metabolomic data generated in collaboration with Genomics England's 100,000 Genomes Project, covering more than 7,500 participants. The company is the first to generate and deliver a metabolomics dataset of this scale for integration with a large national genomic initiative, aiming to advance rare disease research by combining metabolomics with existing genomic and clinical data. The dataset will be made available to approved clinicians and researchers through Genomics England's Trusted Research Environment, with the goal of improving diagnostic yield, supporting disease monitoring, and generating new treatment opportunities for rare diseases.NewswireMetabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease ResearchMetabolon delivered metabolomic data from over 7,500 participants in Genomics England's 100,000 Genomes Project, the first such large-scale dataset for a national genomic initiative. The data will be integrated into the Trusted Research Environment to complement genomic and clinical information for rare disease research.PR NewswireMetabolon élargit l'accès mondial à la métabolomique grâce au kit de profilage métabolomique Metabolon Verus™Metabolon announced the launch of the Metabolon Verus™ Metabolomics Profiling Kit, the company's first kit designed to extend its cutting-edge centralized metabolomics capabilities directly to laboratories worldwide. The kit provides a standardized workflow for generating reproducible metabolomics data with integrated bioinformatics tools for automated data processing and biological interpretation. Announced ahead of the 74th ASMS Conference on Mass Spectrometry, the product addresses long-standing challenges of standardization and reproducibility in metabolomics research.